Drug Pipeline

SHR-1139 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07337564 A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult… Pyoderma Gangrenosum Not Yet Recruiting
NCT07444684 A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum Pyoderma Gangrenosum Not Yet Recruiting
Phase 1
NCT07078695 A Trial of SHR-1139 in Healthy Volunteers Psoriasis Active, Not Recruiting
Sponsors Running SHR-1139 Injection Trials
Atridia Pty Ltd. (1) Shandong First Medical University (1) Guangdong Hengrui Pharmaceutical Co., Ltd (1)
Disease Areas
Psoriasis (1)
Get alerts when SHR-1139 Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free